InvestorsHub Logo
Followers 20
Posts 5326
Boards Moderated 0
Alias Born 01/04/2012

Re: DEVJ post# 7134

Friday, 11/17/2017 10:29:37 AM

Friday, November 17, 2017 10:29:37 AM

Post# of 14859
DEVJ, if AbbVie is the driving force behind the acquisition and it relates to launching at or near Biosimilar launches of Humira in Europe (expected to commence in Q4 2018), we are probably looking at a formal announcement by end of 2018 Q1, at the latest.

JMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News